Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisions
Anyone can find out if a submission has been accepted for review by Health Canada by searching the submissions under review list. We publish Regulatory Decision Summaries (RDS). These summaries explain the purpose of the submission and the reason(s) for Health Canada’s decision on certain health products seeking market authorization. You can access RDSs through the Drug and Health Product Register.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisionsHTMLEnglish publication HTML
-
Canada’s regulatory approach to drugs for rare diseases: find drug reviews and decisionsHTMLFrench publication HTML
Similar records